• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
A20010012 洛匹那韦/利托那韦口服液 lopinavir;ritonavir Oral solution Chemical Drugs New Drug Application 2001-04-23 雅培制药有限公司北京办事处 Abbott Laboratories SA-Beijing Representative Office Approval Completed-Pending Certificated view
JYHB0500696 洛匹那韦/利托那韦口服液体 lopinavir;ritonavir Oral solution Chemical Drugs Supplementary Application 2005-10-21 Abbott Laboratories Certificate Completed-Pending Issued 2006-10-10 view
JYHB1001060 洛匹那韦/利托那韦口服液体 lopinavir;ritonavir Oral solution Chemical Drugs Supplementary Application 2010-12-06 Abbott Laboratories Abbott Laboratories Certificate Issued 2011-07-28 view
JYHB1400912 洛匹那韦/利托那韦口服液体 lopinavir;ritonavir Oral solution Chemical Drugs Supplementary Application 2014-07-25 AbbVie Inc. Abbvie Inc Certificate Issued 2015-01-27 view
JYHB1500411 洛匹那韦/利托那韦口服液体 lopinavir;ritonavir Oral solution Chemical Drugs Supplementary Application 2015-04-10 AbbVie Inc. Abbvie Inc Certificate Issued 2016-05-31 view
JYHB1500712 洛匹那韦/利托那韦口服液体 lopinavir;ritonavir Oral solution Chemical Drugs Supplementary Application 2015-05-25 AbbVie Inc. Abbvie Inc Certificate Issued 2016-07-18 view
JYHB1501395 洛匹那韦/利托那韦口服液体 lopinavir;ritonavir Oral solution Chemical Drugs Supplementary Application 2015-09-28 AbbVie Inc. Abbvie Inc Certificate Issued 2016-07-25 view
JYHB1501553 洛匹那韦/利托那韦口服液体 lopinavir;ritonavir Oral solution Chemical Drugs Supplementary Application 2015-11-04 AbbVie Inc. Abbvie Inc Certificate Issued 2017-06-28 view
JYHB1601611 洛匹那韦/利托那韦口服液体 lopinavir;ritonavir Oral solution Chemical Drugs Supplementary Application 2016-12-06 AbbVie Inc. Abbvie Inc Certificate Issued 2017-05-12 view
JYHB1700852 洛匹那韦/利托那韦口服液体 lopinavir;ritonavir Oral solution Chemical Drugs Supplementary Application 2017-06-16 AbbVie Inc. Abbvie Inc Certificate Issued 2017-11-07 view
JYHB1700867 洛匹那韦/利托那韦口服液体 lopinavir;ritonavir Oral solution Chemical Drugs Supplementary Application 2017-06-19 AbbVie Inc. Abbvie Inc Filed 2017-09-12 view
JYHB1701334 洛匹那韦/利托那韦口服液体 lopinavir;ritonavir Oral solution Chemical Drugs Supplementary Application 2017-10-26 AbbVie Inc. Abbvie Inc Certificate Issued 2018-03-19 view
JYHB1801470 洛匹那韦/利托那韦口服溶液 lopinavir;ritonavir Oral solution Chemical Drugs Supplementary Application 2018-12-13 AbbVie Inc Abbvie Inc Filed 2018-12-19 view
JYHB1900573 洛匹那韦/利托那韦口服溶液 lopinavir;ritonavir Oral solution Chemical Drugs Supplementary Application 2019-05-27 AbbVie Inc Abbvie Inc Certificate Issued 2021-02-25 view
JYHB2000636 洛匹那韦/利托那韦口服溶液 lopinavir;ritonavir Oral solution Chemical Drugs Supplementary Application 2020-05-27 AbbVie Inc Abbvie Inc Filed 2020-06-09 view
JYHB2001571 洛匹那韦/利托那韦口服溶液 lopinavir;ritonavir Oral solution Chemical Drugs Supplementary Application 2020-08-25 AbbVie Inc Abbvie Inc Certificate Issued 2021-02-25 view
JYHZ0700169 洛匹那韦/利托那韦口服液体 lopinavir;ritonavir Oral solution Chemical Drugs License Renew 2007-08-23 Abbott Laboratories Abbott Laboratories Certificate Issued 2008-11-10 view
JYHZ1700300 洛匹那韦/利托那韦口服溶液 lopinavir;ritonavir Oral solution Chemical Drugs License Renew 2018-01-19 AbbVie Inc Abbvie Inc Certificate Issued 2018-08-14 view
JYHZ2300011 洛匹那韦/利托那韦口服溶液 lopinavir;ritonavir Oral solution Chemical Drugs License Renew 2023-01-06 view